who invented glp-1 drugs Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions GLP-1s: What They Are and
Description
Furthermore, these agents modulate inflammation, reduce apoptosis, and improve stem cell functions even under diabetic or inflammatory conditions
Obesity and Type 2 Diabetes has an increasing prevalence worldwide, presenting a major health challenge
The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals
: 1,800/month Earlier, it was 8,80010,000/month
These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases.
